Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
5621 | 1596 | 28.3 | 64% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
230 | 3 | P GLYCOPROTEIN//FMO3//TRIMETHYLAMINURIA | 49374 |
1171 | 2 | JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS//JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS//NONMEM | 9352 |
5621 | 1 | JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS//NONMEM//NONLINEAR MIXED EFFECTS MODEL | 1596 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | journal | 1661492 | 14% | 38% | 226 |
2 | NONMEM | authKW | 815193 | 10% | 26% | 164 |
3 | NONLINEAR MIXED EFFECTS MODEL | authKW | 489039 | 5% | 34% | 75 |
4 | INDIRECT RESPONSE MODELS | authKW | 379967 | 2% | 83% | 24 |
5 | PHARMACOKINET DRUG THER Y | address | 313325 | 3% | 30% | 54 |
6 | PHARMACOMETRICS | authKW | 306735 | 3% | 38% | 42 |
7 | JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS | journal | 275956 | 6% | 14% | 103 |
8 | POPULATION PHARMACOKINETICS | authKW | 240375 | 7% | 11% | 116 |
9 | PHARMACEUT BIOSCI | address | 208629 | 9% | 8% | 136 |
10 | NONLINEAR MIXED EFFECT MODELS | authKW | 197341 | 1% | 74% | 14 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 27156 | 74% | 0% | 1189 |
2 | Statistics & Probability | 5696 | 15% | 0% | 238 |
3 | Medical Informatics | 3803 | 6% | 0% | 98 |
4 | Mathematical & Computational Biology | 2814 | 8% | 0% | 127 |
5 | Computer Science, Interdisciplinary Applications | 260 | 4% | 0% | 65 |
6 | Biology | 203 | 4% | 0% | 62 |
7 | Engineering, Biomedical | 184 | 3% | 0% | 52 |
8 | Computer Science, Theory & Methods | 101 | 3% | 0% | 46 |
9 | Medicine, Research & Experimental | 81 | 4% | 0% | 62 |
10 | Chemistry, Multidisciplinary | 70 | 8% | 0% | 120 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PHARMACOKINET DRUG THER Y | 313325 | 3% | 30% | 54 |
2 | PHARMACEUT BIOSCI | 208629 | 9% | 8% | 136 |
3 | PHARMACOMETR | 185943 | 2% | 28% | 35 |
4 | PL PHARMACOKINET | 117991 | 2% | 16% | 38 |
5 | PHARMACOMETR GRP | 116318 | 1% | 41% | 15 |
6 | PHARMACOKINET PHARMACOMETR | 86085 | 0% | 75% | 6 |
7 | CLIN PHARMACOL MODELLING SIMULAT | 81376 | 1% | 21% | 20 |
8 | UMR 738 | 80263 | 1% | 26% | 16 |
9 | PHARSIGHT CONSULTING SERV | 62604 | 0% | 55% | 6 |
10 | ADV PK PD MODELING SIMULAT | 58293 | 1% | 38% | 8 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | 1661492 | 14% | 38% | 226 |
2 | JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS | 275956 | 6% | 14% | 103 |
3 | AAPS JOURNAL | 87630 | 5% | 6% | 72 |
4 | CLINICAL PHARMACOKINETICS | 26338 | 4% | 2% | 57 |
5 | JOURNAL OF CLINICAL PHARMACOLOGY | 24791 | 5% | 2% | 84 |
6 | JOURNAL OF BIOPHARMACEUTICAL STATISTICS | 22730 | 2% | 4% | 33 |
7 | CLINICAL PHARMACOLOGY & THERAPEUTICS | 18406 | 5% | 1% | 75 |
8 | PHARMACEUTICAL RESEARCH | 15233 | 5% | 1% | 80 |
9 | PHARMACEUTICAL STATISTICS | 10498 | 1% | 3% | 17 |
10 | STATISTICS IN MEDICINE | 6601 | 3% | 1% | 50 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NONMEM | 815193 | 10% | 26% | 164 | Search NONMEM | Search NONMEM |
2 | NONLINEAR MIXED EFFECTS MODEL | 489039 | 5% | 34% | 75 | Search NONLINEAR+MIXED+EFFECTS+MODEL | Search NONLINEAR+MIXED+EFFECTS+MODEL |
3 | INDIRECT RESPONSE MODELS | 379967 | 2% | 83% | 24 | Search INDIRECT+RESPONSE+MODELS | Search INDIRECT+RESPONSE+MODELS |
4 | PHARMACOMETRICS | 306735 | 3% | 38% | 42 | Search PHARMACOMETRICS | Search PHARMACOMETRICS |
5 | POPULATION PHARMACOKINETICS | 240375 | 7% | 11% | 116 | Search POPULATION+PHARMACOKINETICS | Search POPULATION+PHARMACOKINETICS |
6 | NONLINEAR MIXED EFFECT MODELS | 197341 | 1% | 74% | 14 | Search NONLINEAR+MIXED+EFFECT+MODELS | Search NONLINEAR+MIXED+EFFECT+MODELS |
7 | MODEL BASED DRUG DEVELOPMENT | 138837 | 1% | 48% | 15 | Search MODEL+BASED+DRUG+DEVELOPMENT | Search MODEL+BASED+DRUG+DEVELOPMENT |
8 | SAEM | 136642 | 1% | 71% | 10 | Search SAEM | Search SAEM |
9 | TURNOVER MODELS | 133915 | 0% | 100% | 7 | Search TURNOVER+MODELS | Search TURNOVER+MODELS |
10 | SAMPLING WINDOWS | 117174 | 0% | 88% | 7 | Search SAMPLING+WINDOWS | Search SAMPLING+WINDOWS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | LEANDER, J , ALMQUIST, J , AHLSTROM, C , GABRIELSSON, J , JIRSTRAND, M , (2015) MIXED EFFECTS MODELING USING STOCHASTIC DIFFERENTIAL EQUATIONS: ILLUSTRATED BY PHARMACOKINETIC DATA OF NICOTINIC ACID IN OBESE ZUCKER RATS.AAPS JOURNAL. VOL. 17. ISSUE 3. P. 586 -596 | 27 | 100% | 3 |
2 | VOZEH, S , STEIMER, JL , ROWLAND, M , MORSELLI, P , MENTRE, F , BALANT, LP , AARONS, L , (1996) THE USE OF POPULATION PHARMACOKINETICS IN DRUG DEVELOPMENT.CLINICAL PHARMACOKINETICS. VOL. 30. ISSUE 2. P. 81 -93 | 70 | 57% | 76 |
3 | OGUNGBENRO, K , AARONS, L , (2007) DESIGN OF POPULATION PHARMACOKINETIC EXPERIMENTS USING PRIOR INFORMATION.XENOBIOTICA. VOL. 37. ISSUE 10-11. P. 1311 -1330 | 40 | 77% | 7 |
4 | DOKOUMETZIDIS, A , AARONS, L , OGUNGBENRO, K , (2009) APPLICATION OF OPTIMAL DESIGN METHODOLOGIES IN CLINICAL PHARMACOLOGY EXPERIMENTS.PHARMACEUTICAL STATISTICS. VOL. 8. ISSUE 3. P. 239 -252 | 40 | 71% | 11 |
5 | PLAN, EL , MALONEY, A , MENTRE, F , KARLSSON, MO , BERTRAND, J , (2012) PERFORMANCE COMPARISON OF VARIOUS MAXIMUM LIKELIHOOD NONLINEAR MIXED-EFFECTS ESTIMATION METHODS FOR DOSE-RESPONSE MODELS.AAPS JOURNAL. VOL. 14. ISSUE 3. P. 420 -432 | 27 | 96% | 10 |
6 | PILLAI, G , MENTRE, F , STEIMER, JL , (2005) NON-LINEAR MIXED EFFECTS MODELING - FROM METHODOLOGY AND SOFTWARE DEVELOPMENT TO DRIVING IMPLEMENTATION IN DRUG DEVELOPMENT SCIENCE.JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS. VOL. 32. ISSUE 2. P. 161-183 | 40 | 74% | 38 |
7 | NYBERG, J , BAZZOLI, C , OGUNGBENRO, K , ALIEV, A , LEONOV, S , DUFFULL, S , HOOKER, AC , MENTRE, F , (2015) METHODS AND SOFTWARE TOOLS FOR DESIGN EVALUATION IN POPULATION PHARMACOKINETICS-PHARMACODYNAMICS STUDIES.BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. VOL. 79. ISSUE 1. P. 6 -17 | 21 | 91% | 9 |
8 | NGUYEN, TT , BAZZOLI, C , MENTRE, F , (2012) DESIGN EVALUATION AND OPTIMISATION IN CROSSOVER PHARMACOKINETIC STUDIES ANALYSED BY NONLINEAR MIXED EFFECTS MODELS.STATISTICS IN MEDICINE. VOL. 31. ISSUE 11-12. P. 1043 -1058 | 25 | 93% | 5 |
9 | AARONS, L , OGUNGBENRO, K , (2010) OPTIMAL DESIGN OF PHARMACOKINETIC STUDIES.BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. VOL. 106. ISSUE 3. P. 250 -255 | 27 | 84% | 14 |
10 | TOD, M , JULLIEN, V , PONS, G , (2008) FACILITATION OF DRUG EVALUATION IN CHILDREN BY POPULATION METHODS AND MODELLING.CLINICAL PHARMACOKINETICS. VOL. 47. ISSUE 4. P. 231-243 | 41 | 47% | 94 |
Classes with closest relation at Level 1 |